Pharmaceutical company Novo Nordisk has managed to lower its CO2 emissions by 30 percent despite significantly increasing production. The reduction is so large that the company has now reached its goal for cutting greenhouse gas emissions five years ahead of target, reports trade journal Ingeniøren.
A target of a 10 percent reduction by 2014 was set in 2004 and, even though the company produced more insulin during the period, the target was easily reached ahead of schedule.

Climate







